Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study
1 other identifier
observational
150
1 country
1
Brief Summary
The treatment of Growth Hormone deficiency (GHD) patients with GH, often induce fluid retention; this effect is dose dependent and temporary. The symptoms are swelling of soft tissue and joint stiffness. The objective of this study is to create bioelectric impedance/arm muscle area (BIA/AMA) reference data, as a measurement of hydration status, of healthy persons of both genders in the age 20-70 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 7, 2010
CompletedFirst Posted
Study publicly available on registry
May 11, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedNovember 7, 2011
November 1, 2011
1.2 years
May 7, 2010
November 4, 2011
Conditions
Study Arms (2)
Male
Female
Eligibility Criteria
The subjects are healthy persons in the age 20-70 years, both males and females will be recruited from the city Aarhus in Denmark.
You may qualify if:
- Healthy persons,
- Age 20- 70 years.
You may not qualify if:
- Cardiac implanter (pacemaker),
- Heart insufficiency, chronic venuos insufficiency,
- Use of diuretics, desmopressin, neuroleptica, antidepressants, corticosteroids, fludrocotidon,
- Obesity (BMI \> 30),
- Knowledge of changes in electrolyte or water homeostasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus university hospital NBG
Aarhus, 8000, Denmark
Biospecimen
Blood sample to measure "Insulin like growth factor-1" (IGF-1)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens O Jørgnsen, Professor
University of Aarhus
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2010
First Posted
May 11, 2010
Study Start
May 1, 2010
Primary Completion
July 1, 2011
Study Completion
August 1, 2011
Last Updated
November 7, 2011
Record last verified: 2011-11